Symbol: |
CAPS2
|
Description: |
calcyphosine 2 [Source:HGNC Symbol;Acc:16471]
|
Location: |
Chr12:75669759-75784708[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:194
Gene |
Compound |
Gen_sig |
Exp_pattern |
CAPS2 |
Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- |
0.004 |
Up |
CAPS2 |
3-Pyridinecarbonitrile, 6-[4-[(7-chloro-4-quinolinyl)amino]phenyl]-1,2-dihydro- 4-(4-methoxy-1-naphthalenyl)-2-oxo- |
0.046 |
Up |
CAPS2 |
2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- |
0.011 |
Up |
CAPS2 |
NSC 703108 |
0.038 |
Up |
CAPS2 |
NSC 703162 |
0.011 |
Up |
CAPS2 |
NSC 703855 |
0.003 |
Up |
CAPS2 |
NSC 704171 |
0.039 |
Up |
CAPS2 |
NSC 704172 |
0.009 |
Up |
CAPS2 |
NSC 704430 |
0.045 |
Down |
CAPS2 |
NSC 704964 |
0.026 |
Down |
CAPS2 |
2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- |
0.048 |
Up |
CAPS2 |
Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- |
0.031 |
Up |
CAPS2 |
NSC 709969 |
0.003 |
Up |
CAPS2 |
7H-Thieno[3',4':3,4]cyclopent[1,2-d]oxazol-7-one, 4,6-dibromo-1,2,3a,7a-tetrahydro-2-thioxo-, CIS- |
0.004 |
Up |
CAPS2 |
NSC 713599 |
0.044 |
Up |
Expression pattern: Sensitivity / Resistance
Total:13 Current:10
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:3
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:57
Total:4 Current:1
[First] [Prev]  Next Last 
|